# Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure After G6PD Testing in Thailand

> **NCT05753150** · — · COMPLETED · sponsor: **Dr. Prayuth Sudathip** · enrollment: 187 (actual)

## Conditions studied

- Malaria, Vivax
- G6PD Deficiency

## Interventions

- **DRUG:** Tafenoquine
- **DRUG:** Primaquine
- **DRUG:** Primaquine

## Key facts

- **NCT ID:** NCT05753150
- **Lead sponsor:** Dr. Prayuth Sudathip
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-23
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-10-01
- **Target enrollment:** 187 (ACTUAL)
- **Last updated:** 2023-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05753150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05753150, "Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure After G6PD Testing in Thailand". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05753150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*